股票 › CGEM
Cullinan 制药 CGEM
美股市值排名 #3426
$11.31 +$0.51 (+4.72%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $11.51 +1.77%
开盘$11.09
昨收$10.80
当日区间$10.69 – $11.77
成交量755.7K
市值$727.85M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$57.25M+24.5% YoY
净利润-$53.70M+23.3% YoY
摊薄每股收益-$0.81+24.3% YoY
自由现金流-$38.22M+33.7% YoY
经营现金流-$38.22M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-50.3%
资产收益率-46.3%
投入资本回报率-54.3%
流动比率8.42
负债/资产比率11.6%
现金及投资$334.54M
总负债$1.41M
净现金（净负债）$333.13M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $57.25M | $53.70M | $241.65M | $55.26M | $55.60M |
| 销售及管理费用 | $12.82M | $11.57M | $54.25M | $12.31M | $13.63M |
| -管理费用 | $12.82M | $11.57M | $54.25M | $12.31M | $13.63M |
| 研发费用 | $44.44M | $42.12M | $187.40M | $42.95M | $41.97M |
| 营业利润 | -$57.25M | -$53.70M | -$241.65M | -$55.26M | -$55.60M |
| 非经营性利息净收入（支出） | $3.65M | $4.10M | $22.21M | $4.62M | $5.09M |
| 非经营性利息收入 | $3.65M | $4.10M | $22.21M | $4.62M | $5.09M |
| 其他收入（支出） | -$98,000.00 | -$62,000.00 | -$443,000.00 | -$69,000.00 | -$108,000.00 |
| 其他非经营性收入（支出） | -$98,000.00 | -$62,000.00 | -$443,000.00 | -$69,000.00 | -$108,000.00 |
| 税前利润 | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| 净利润 | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| 持续经营利润 | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| 归属母公司净利润 | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| 归属普通股股东净利润 | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| 基本每股收益 | -$0.81 | -$0.75 | -$3.36 | -$0.77 | -$0.77 |
| 摊薄每股收益 | -$0.81 | -$0.75 | -$3.36 | -$0.77 | -$0.77 |
| 税费 | – | – | $0.00 | – | – |
| 少数股东权益 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $363.79M | $402.98M | $448.37M | $448.37M | $484.13M |
| 流动资产合计 | $341.97M | $361.41M | $386.76M | $386.76M | $342.24M |
| 现金及现金等价物与短期投资 | $334.54M | $351.89M | $377.90M | $377.90M | $332.60M |
| -现金及现金等价物 | $78.64M | $75.08M | $88.33M | $88.33M | $103.34M |
| -短期投资 | $255.90M | $276.80M | $289.56M | $289.56M | $229.26M |
| 其他流动资产 | $7.44M | $9.52M | $8.86M | $8.86M | $9.64M |
| 非流动资产合计 | $21.81M | $41.58M | $61.62M | $61.62M | $141.89M |
| 固定资产净值 | $2.50M | $2.78M | $3.05M | $3.05M | $1.54M |
| -固定资产原值 | $2.50M | $2.78M | $4.02M | $4.02M | $1.54M |
| 投资及预付款 | $19.02M | $38.50M | $58.27M | $58.27M | $140.00M |
| -持有至到期证券 | $19.02M | $38.50M | $58.27M | $58.27M | $140.00M |
| 其他非流动资产 | $297,000.00 | $297,000.00 | $297,000.00 | $297,000.00 | $361,000.00 |
| 负债合计 | $42.03M | $36.81M | $39.64M | $39.64M | $32.76M |
| 流动负债合计 | $40.63M | $35.15M | $37.74M | $37.74M | $32.76M |
| 应付款 | $10.70M | $8.14M | $9.63M | $9.63M | $6.96M |
| -应付账款 | $3.73M | $2.51M | $841,000.00 | $841,000.00 | $1.72M |
| -其他应付款 | $6.97M | $5.63M | $8.78M | $8.78M | $5.24M |
| 一年内应计费用 | $22.80M | $21.94M | $16.39M | $16.39M | $15.72M |
| 短期债务及融资租赁负债 | $666,000.00 | $725,000.00 | $780,000.00 | $780,000.00 | $1.19M |
| -一年内到期融资租赁负债 | $666,000.00 | $725,000.00 | $780,000.00 | $780,000.00 | $1.19M |
| 其他流动负债 | $1.53M | $1.35M | $996,000.00 | $996,000.00 | $1.52M |
| 非流动负债合计 | $1.41M | $1.66M | $1.90M | $1.90M | $0.00 |
| 长期债务及融资租赁负债 | $1.41M | $1.66M | $1.90M | $1.90M | $0.00 |
| -长期融资租赁负债 | $1.41M | $1.66M | $1.90M | $1.90M | $0.00 |
| 股东权益合计 | $321.75M | $366.17M | $408.73M | $408.73M | $451.37M |
| 股东权益 | $321.75M | $366.17M | $408.73M | $408.73M | $451.37M |
| 股本 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -普通股 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.01B | $1.00B | $995.82M | $995.82M | $987.80M |
| 留存收益 | -$691.48M | -$637.78M | -$588.12M | -$588.12M | -$537.41M |
| 不影响留存收益的损益 | -$134,000.00 | $127,000.00 | $1.02M | $1.02M | $973,000.00 |
| -累计折旧 | – | – | -$969,000.00 | -$969,000.00 | – |
| 少数股东权益 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$38.22M | -$46.05M | -$175.75M | -$38.11M | -$36.88M |
| 持续经营经营活动现金流净额 | -$38.22M | -$46.05M | -$175.75M | -$38.11M | -$36.88M |
| 持续经营净利润 | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| 折旧、折耗与摊销 | $79,000.00 | $79,000.00 | $311,000.00 | $79,000.00 | $79,000.00 |
| 营运资金变动 | $7.51M | -$3.30M | $14.08M | $6.14M | $5.55M |
| -预付资产变动 | $2.09M | -$662,000.00 | $6.90M | $840,000.00 | $798,000.00 |
| -应付账款及应计费用变动 | $5.43M | -$2.64M | $7.19M | $5.30M | $4.75M |
| 投资活动现金流净额 | $40.68M | $32.41M | $179.99M | $22.39M | $67.39M |
| 持续经营投资活动现金流净额 | $40.68M | $32.41M | $179.99M | $22.39M | $67.39M |
| 投资购置及出售净额 | $40.68M | $32.41M | $180.04M | $22.40M | $67.43M |
| 筹资活动现金流 | $1.10M | $380,000.00 | $1.09M | $715,000.00 | $0.00 |
| 持续经营筹资活动现金流净额 | $1.10M | $380,000.00 | $1.09M | $715,000.00 | $0.00 |
| 股票期权行使所得 | $1.10M | $380,000.00 | $1.09M | $715,000.00 | $0.00 |
| 期末现金余额 | $78.64M | $75.08M | $88.33M | $88.33M | $103.34M |
| 现金净变动 | $3.56M | -$13.25M | $5.33M | -$15.00M | $30.52M |
| 期初现金余额 | $75.08M | $88.33M | $83.01M | $103.34M | $72.82M |
| 自由现金流 | -$38.22M | -$46.05M | -$175.80M | -$38.12M | -$36.92M |
| 固定资产购置及出售净额 | – | – | -$49,000.00 | -$11,000.00 | – |
| 普通股发行净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 CGEM。
登录后参与讨论。